A detailed history of Bank Of America Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 283,331 shares of HRMY stock, worth $9.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
283,331
Previous 73,806 283.89%
Holding current value
$9.72 Million
Previous $2.48 Million 244.96%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $6.04 Million - $6.92 Million
209,525 Added 283.89%
283,331 $8.55 Million
Q1 2024

May 15, 2024

BUY
$29.93 - $35.06 $1.18 Million - $1.38 Million
39,461 Added 114.9%
73,806 $2.48 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $193,536 - $340,502
10,080 Added 41.54%
34,345 $1.11 Million
Q2 2023

Aug 14, 2023

SELL
$30.5 - $37.4 $760,944 - $933,092
-24,949 Reduced 50.69%
24,265 $853,000
Q1 2023

May 12, 2023

BUY
$30.8 - $53.92 $98,344 - $172,166
3,193 Added 6.94%
49,214 $1.61 Million
Q4 2022

Feb 10, 2023

BUY
$45.4 - $60.91 $45,990 - $61,701
1,013 Added 2.25%
46,021 $2.54 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $548,630 - $723,289
13,044 Added 40.81%
45,008 $1.99 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $145,697 - $226,539
4,344 Added 15.73%
31,964 $1.56 Million
Q1 2022

May 16, 2022

SELL
$33.14 - $51.13 $311,714 - $480,928
-9,406 Reduced 25.4%
27,620 $1.34 Million
Q4 2021

Feb 08, 2022

BUY
$34.09 - $43.91 $731,605 - $942,352
21,461 Added 137.88%
37,026 $1.58 Million
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $259,239 - $389,767
10,095 Added 184.55%
15,565 $597,000
Q2 2021

Sep 13, 2021

BUY
$25.96 - $33.44 $142,001 - $182,916
5,470 New
5,470 $155,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.03B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.